Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Brightening Your Vision With Fractional Flow Reserve and Intravascular Ultrasound

  • Jung-Joon Cha (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine) ;
  • Soon Jun Hong (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine)
  • Received : 2024.06.29
  • Accepted : 2024.07.01
  • Published : 2024.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Hannan EL, Zhong Y, Reddy P, et al. Percutaneous coronary intervention with and without intravascular ultrasound for patients with complex lesions: utilization, mortality, and target vessel revascularization. Circ Cardiovasc Interv 2022;15:e011687.
  2. Parikh RV, Liu G, Plomondon ME, et al. Utilization and outcomes of measuring fractional flow reserve in patients with stable ischemic heart disease. J Am Coll Cardiol 2020;75:409-19. https://doi.org/10.1016/j.jacc.2019.10.060
  3. Ahn SG, Lee SJ. Dose coronary angiography suffice for assessment of intermediate coronary stenosis? Korean Circ J 2019;49:1033-4. https://doi.org/10.4070/kcj.2019.0227
  4. De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014;371:1208-17. https://doi.org/10.1056/NEJMoa1408758
  5. Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc Interv 2016;9:e003700.
  6. Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv 2019;12:e007023.
  7. Cha JJ, Kim D, Kim BK, et al. Association between angiographic and intravascular ultrasound optimizations after new-generation drug-eluting stent implantation and clinical outcomes. Coron Artery Dis 2021;32:541-8. https://doi.org/10.1097/MCA.0000000000001007
  8. Lee JH, Ahn SG, Jeon HS, et al. Discordance between angiographic assessment and fractional flow reserve or intravascular ultrasound in intermediate coronary lesions: a post-hoc analysis of the FLAVOUR trial. Korean Circ J 2024;54:485-96. https://doi.org/10.4070/kcj.2024.0046
  9. Park SJ, Ahn JM, Kang DY, et al. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet 2024;403:1753-65. https://doi.org/10.1016/S0140-6736(24)00413-6
  10. Yang S, Koo BK. Coronary physiology-based approaches for plaque vulnerability: implications for risk prediction and treatment strategies. Korean Circ J 2023;53:581-93. https://doi.org/10.4070/kcj.2023.0117